Overview
NRG Therapeutics is a biotechnology company developing first-in-class, orally bioavailable mitochondrial inhibitors designed to trigger mitochondrial DNA release and activate the cGAS/STING pathway for treating neurodegenerative diseases. The company's therapeutic approach targets pathogenic protein-related conditions, including ALS, through novel mechanisms rooted in neuroscience and mitochondrial biology research.
More in Neurotechnology
Latest industry news
Precision Neuroscience Raises $250M to Accelerate Brain-Computer Interface Development
2026-11-01 · Funding
Merge Labs Gets Competition as New Rival Neurotech Startup Enters the Consumer BCI Arena
2026-10-31 · Industry
Neuralink Connects to Grok AI Agent, Enabling ALS Patient to Control AI and Make Calls by Thought Alone
2026-10-30 · Product
Implanted BCIs Still Lack a Shared Safety Rulebook, and the Field Is Running Out of Time to Write One
2026-10-29 · Research
Company details
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →